Clinical Edge

Summaries of Must-Read Clinical Literature, Guidelines, and FDA Actions

Trends in Pediatric Inpatients with ITP

J Pediatr Hematol Oncol; ePub 2018 Jan 12; Okubo, et al

A recently analysis of children and adolescents with immune thrombocytopenia (ITP) provided insights on its epidemiology and impact on utilization. Investigators assessed hospital discharge records of participants aged ≤19 years with ITP over a 10-year period ending in 2012. They looked at health care utilization, hospitalization costs, and length of stay. Among the results:

  • Total annual ITP hospitalization rates were not significantly different in 2003 and 2012 (6.13 vs 6.22/100,000 children).
  • Lowest proportions of hospitalizations were seen in August.
  • 19% of inpatients were treated with intravenous immunoglobulin in 2003, compared with 40% in 2012.
  • Bone marrow aspiration was performed in 8% and 7%, respectively.
  • Total hospitalization costs were ~$6,150 and $~9,300, respectively.
  • Lengths of stay were 3.78 and 2.55 days, respectively.

Citation:

Okubo Y, Handa A. Nationwide trend analysis of pediatric inpatients with immune thrombocytopenia in the United States. [Published online ahead of print January 12, 2018]. J Pediatr Hematol Oncol.

doi:10.1097/MPH.0000000000001083.